Duration and Dose of Adjuvant Zoledronic Acid for Treatment of Early Breast Cancer-Reply
JAMA Oncol
.
2022 Jan 1;8(1):171-172.
doi: 10.1001/jamaoncol.2021.5768.
Authors
Thomas W P Friedl
1
,
Wolfgang Janni
1
,
Brigitte Rack
1
Affiliation
1
Department of Gynecology and Obstetrics, University Hospital Ulm, Ulm, Germany.
PMID:
34792528
DOI:
10.1001/jamaoncol.2021.5768
No abstract available
Publication types
Letter
Comment
MeSH terms
Breast Neoplasms* / drug therapy
Chemotherapy, Adjuvant
Diphosphonates / adverse effects
Female
Humans
Zoledronic Acid / therapeutic use
Substances
Diphosphonates
Zoledronic Acid